Mylan, Pfizer, Others Ordered to Face Dermatology Antitrust Case

Mylan NV, Pfizer Inc., and other pharmaceutical companies lost their bid to end antitrust litigation brought by nearly every state attorney general over an alleged industrywide scheme to inflate the cost of generic dermatology products.

Judge Cynthia M. Rufe let the lawsuit move forward Tuesday with claims of an “overarching conspiracy” among the drugmakers to fix the price of 80 different skin treatments. The dispute is part of a broader multidistrict case targeting virtually the entire generic drug sector.

If true, the allegations show the companies used coded language about giving each one its “fair share” of the ...